Expert Review of Pharmacoeconomics & Outcomes Research
Volume 20, 2020 - Issue 6
Original Research
Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary
, 
, , , &
Marcell Csanádic Syreon Research Institute, Budapest, Hungary;d Department of Pharmaceutics and Central Clinical Pharmacy, University of Pécs, Pécs, Hungaryhttps://orcid.org/0000-0002-5724-639XView further author information
https://orcid.org/0000-0002-5724-639XView further author information, , , Zoltán Kalóa Department of Health Policy and Health Economics, Eötvös Loránd University (ELTE), Budapest, Hungary;c Syreon Research Institute, Budapest, Hungaryhttps://orcid.org/0000-0001-7762-2607View further author information
https://orcid.org/0000-0001-7762-2607View further author information & 